Benzenesulfonamide compounds and their use as therapeutic agents
US11299490B2 · kind B2 · utility
1Cited by
11References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 2020 |
| Grant date | Apr 12, 2022 |
| Priority date | — |
| Expiry date | Jul 28, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.